The effect of chemotherapy on the exposure–response relation of abiraterone in metastatic castration‐resistant prostate cancer

AIMS: To assess whether the exposure–response relation for abiraterone is different in pre‐chemotherapy patients compared to post‐chemotherapy patients with metastatic castration‐resistant prostate cancer (mCRPC). METHODS: Data were collected from three clinical studies in mCRPC patients treated wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Boerrigter, Emmy, Benoist, Guillemette E., Overbeek, Joanneke K., Donders, Rogier, Mehra, Niven, van Oort, Inge M., ter Heine, Rob, van Erp, Nielka P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293353/
https://www.ncbi.nlm.nih.gov/pubmed/34436788
http://dx.doi.org/10.1111/bcp.15057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293353/
https://www.ncbi.nlm.nih.gov/pubmed/34436788
http://dx.doi.org/10.1111/bcp.15057

Ejemplares similares